参考文献
关键文献
Centers for Disease Control and Prevention. Highly pathogenic avian influenza A(H5N1) virus in animals: interim recommendations for prevention, monitoring, and public health investigations. Jun 2024 [internet publication].全文
Centers for Disease Control and Prevention. Interim guidance on the use of antiviral medications for treatment of human infections with novel influenza A viruses associated with severe human disease. Sep 2024 [internet publication].全文
Centers for Disease Control and Prevention. Interim guidance on specimen collection and testing for patients with suspected infection with novel influenza A viruses associated with severe disease or with the potential to cause severe disease in humans. Sep 2024 [internet publication].全文
World Health Organization. Clinical practice guidelines for influenza. Sep 2024 [internet publication].全文
Centers for Disease Control and Prevention. Interim guidance for follow-up of close contacts of persons infected with novel influenza A viruses associated with severe human disease or with potential to cause severe human disease, and use of antiviral medications for post-exposure prophylaxis. Aug 2024 [internet publication].全文
参考文献
1. Ungchusak K, Auewarakul P, Dowell SF, et al. Probable person-to-person transmission of avian influenza A (H5N1). N Engl J Med. 2005 Jan 27;352(4):333-40.全文 摘要
2. Wang H, Feng Z, Shu Y, et al. Probable limited person-to-person transmission of highly pathogenic avian influenza A (H5N1) virus in China. Lancet. 2008 Apr 26;371(9622):1427-34. 摘要
3. Centers for Disease Control and Prevention. Current H5N1 bird flu situation in dairy cows. Oct 2024 [internet publication].全文
4. Skowronski DM, Tweed SA, Petric M, et al. Human illness and isolation of low-pathogenicity avian influenza virus of the H7N3 subtype in British Columbia, Canada. J Infect Dis. 2006 Mar 15;193(6):899-900. 摘要
5. Peiris M, Yuen KY, Leung CW, et al. Human infection with influenza H9N2. Lancet. 1999 Sep 11;354(9182):916-7. 摘要
6. Uyeki TM, Chong YH, Katz JM, et al. Lack of evidence for human-to-human transmission of avian influenza A (H9N2) viruses in Hong Kong, China 1999. Emerg Infect Dis. 2002 Feb;8(2):154-9.全文 摘要
7. Eurosurveillance editorial team. Avian influenza A/(H7N2) outbreak in the United Kingdom. Euro Surveill. 2007 May 31;12(5):E070531.全文 摘要
8. Kurtz J, Manvell RJ, Banks J. Avian influenza virus isolated from a woman with conjunctivitis. Lancet. 1996 Sep 28;348(9031):901-2. 摘要
9. Zhuang Y, Wang M, Liang L, et al. First known human death after infection with the avian influenza A/H3N8 virus: Guangdong Province, China, March 2023. Clin Infect Dis. 2024 Mar 20;78(3):646-50.全文 摘要
10. Qi X, Qiu H, Hao S, et al. Human infection with an avian-origin influenza A (H10N3) virus. N Engl J Med. 2022 Mar 17;386(11):1087-8.全文 摘要
11. Tong XC, Weng SS, Xue F, et al. First human infection by a novel avian influenza A(H7N4) virus. J Infect. 2018 Sep;77(3):249-57. 摘要
12. Tweed SA, Skowronski DM, David ST, et al. Human illness from avian influenza H7N3, British Columbia. Emerg Infect Dis. 2004 Dec;10(12):2196-9.全文 摘要
13. Nguyen-Van-Tam JS, Nair P, Acheson P, et al. Outbreak of low pathogenicity H7N3 avian influenza in UK, including associated case of human conjunctivitis. Euro Surveill. 2006 May 4;11(5):E060504.全文 摘要
14. Pan M, Gao R, Lv Q, et al. Human infection with a novel, highly pathogenic avian influenza A (H5N6) virus: virological and clinical findings. J Infect. 2016 Jan;72(1):52-9. 摘要
15. Yang ZF, Mok CK, Peiris JS, et al. Human infection with a novel avian influenza A (H5N6) virus. N Engl J Med. 2015 Jul 30;373(5):487-9.全文 摘要
16. World Health Organization/World Organisation for Animal Health/Food and Agriculture Organization H5N1 Evolution Working Group. Revised and updated nomenclature for highly pathogenic avian influenza A (H5N1) viruses. Influenza Other Respir Viruses. 2014 May;8(3):384-8.全文 摘要
17. World Health Organization. Evolution of the influenza A(H5) haemagglutinin: WHO/OIE/FAO H5 Working Group reports a new clade designated 2.3.4.4. Jan 2015 [internet publication].全文
18. Smith GJ, Donis RO; World Health Organization/World Organisation for Animal Health/Food and Agriculture Organization (WHO/OIE/FAO) H5 Evolution Working Group. Nomenclature updates resulting from the evolution of avian influenza A(H5) virus clades 2.1.3.2a, 2.2.1, and 2.3.4 during 2013-2014. Influenza Other Respir Viruses. 2015 Sep;9(5):271-6.全文 摘要
19. World Health Organization. Genetic and antigenic characteristics of zoonotic influenza A viruses and development of candidate vaccine viruses for pandemic preparedness. Feb 2023 [internet publication].全文
20. Centers for Disease Control and Prevention. Technical report: June 2024 highly pathogenic avian influenza A(H5N1) viruses. Jun 2024 [internet publication].全文
21. World Health Organization. Assessment of risk associated with recent influenza A(H5N1) clade 2.3.4.4b viruses. Dec 2022 [internet publication].全文
22. Centers for Disease Control and Prevention. H5 bird flu: current situation. Oct 2024 [internet publication].全文
23. World Health Organization. Genetic and antigenic characteristics of clade 2.3.4.4b A(H5N1) viruses identified in dairy cattle in the United States of America. May 2024 [internet publication].全文
24. Centers for Disease Control and Prevention. Technical update: summary analysis of the genetic sequence of a highly pathogenic avian influenza A(H5N1) virus identified in a human in Michigan. May 2024 [internet publication].全文
25. World Health Organization. Update on human cases of highly pathogenic avian influenza A(H5N1) virus infection, 2010. Wkly Epidemiol Rec. 2011 Apr 22;86(17):161-6.全文 摘要
26. Uyeki TM. Human infection with highly pathogenic avian influenza A (H5N1) virus: review of clinical issues. Clin Infect Dis. 2009 Jul 15;49(2):279-90.全文 摘要
27. de Jong MD, Bach VC, Phan TQ, et al. Fatal avian influenza A (H5N1) in a child presenting with diarrhea followed by coma. N Engl J Med. 2005 Feb 17;352(7):686-91.全文 摘要
28. Rajabali N, Lim T, Sokolowski C, et al. Avian influenza A (H5N1) infection with respiratory failure and meningoencephalitis in a Canadian traveller. Can J Infect Dis Med Microbiol. 2015 Jul-Aug;26(4):221-3.全文 摘要
29. Kandeel A, Manoncourt S, Abd el Kareem E, et al. Zoonotic transmission of avian influenza virus (H5N1), Egypt, 2006-2009. Emerg Infect Dis. 2010 Jul;16(7):1101-7.全文 摘要
30. International Centre for Diarrhoeal Disease Research, Bangladesh (ICDDR,B). Outbreak of mild respiratory disease caused by H5N1 and H9N2 infections among young children in Dhaka, Bangladesh, 2011. Health Sci Bulletin. 2011;9:1-12.全文
31. Oner AF, Dogan N, Gasimov V, et al. H5N1 avian influenza in children. Clin Infect Dis. 2012 Jul;55(1):26-32.全文 摘要
32. Shinde V, Hanshaoworakul W, Simmerman JM, et al. A comparison of clinical and epidemiological characteristics of fatal human infections with H5N1 and human influenza viruses in Thailand, 2004-2006. PLoS One. 2011 Apr 29;6(4):e14809.全文 摘要
33. Chan PK. Outbreak of avian influenza A(H5N1) virus infection in Hong Kong in 1997. Clin Infect Dis. 2002 May 1;34(suppl 2):S58-64.全文 摘要
34. Peiris JS, Yu WC, Leung CW, et al. Re-emergence of fatal human influenza A subtype H5N1 disease. Lancet. 2004 Feb 21;363(9409):617-9.全文 摘要
35. World Health Organization. Cumulative number of confirmed human cases for avian influenza A(H5N1) reported to WHO, 2003-2024, 19 July 2024. Jul 2024 [internet publication].全文
36. UK Health Security Agency. Avian influenza (influenza A H5N1): risk to human health. Jul 2024 [internet publication].全文
37. Centers for Disease Control and Prevention. Highly pathogenic avian influenza A(H5N1) virus in animals: interim recommendations for prevention, monitoring, and public health investigations. Jun 2024 [internet publication].全文
38. Centers for Disease Control and Prevention. Interim guidance on the use of antiviral medications for treatment of human infections with novel influenza A viruses associated with severe human disease. Sep 2024 [internet publication].全文
39. World Health Organization. Disease outbreak news: avian influenza A(H5N1) - United States of America. Apr 2024 [internet publication].全文
40. Centers for Disease Control and Prevention. Highly pathogenic avian influenza A (H5N1) virus infection reported in a person in the U.S. Apr 2024 [internet publication].全文
41. Centers for Disease Control and Prevention. CDC reports second human case of H5 bird flu tied to dairy cow outbreak. May 2024 [internet publication].全文
42. Centers for Disease Control and Prevention. CDC confirms second human H5 bird flu case in Michigan; third case tied to dairy outbreak. May 2024 [internet publication].全文
43. Centers for Disease Control and Prevention. CDC reports fourth human case of H5 bird flu tied to dairy cow outbreak. Jul 2024 [internet publication].全文
44. Drehoff CC, White EB, Frutos AM. Cluster of influenza A(H5) cases associated with poultry exposure at two facilities — Colorado, July 2024. Weekly. 2024 Aug; 73(34):734-9.全文
45. Centers for Disease Control and Prevention. CDC confirms human H5 Bird flu case in Missouri. Sep 2024 [internet publication].全文
46. Centers for Disease Control and Prevention. CDC confirms new human cases of H5 bird flu in California. Oct 2024 [internet publication].全文
47. Centers for Disease Control and Prevention. CDC confirms 3rd human case of H5 bird flu in California. Oct 2024 [internet publication].全文
48. World Health Organization. Avian influenza A(H5N1) - Cambodia. Sep 2024 [internet publication].全文
49. World Health Organization. Avian influenza A (H5N1): Australia. Jun 2024 [internet publication].全文
50. World Health Organization. Disease outbreak news: avian influenza A(H5N1) - Viet Nam. Apr 2024 [internet publication].全文
51. World Health Organization. Disease outbreak news: avian influenza A (H5N1) - Cambodia. Feb 2024 [internet publication].全文
52. World Health Oragnization. Disease outbreak news: avian influenza A (H5N1) - Cambodia. Nov 2023 [internet publication].全文
53. World Health Organization. Disease outbreak news: avian influenza A H5N1 - United Kingdom of Great Britain and Northern Ireland. May 2023 [internet publication].全文
54. World Health Organization. Disease outbreak news: human infection caused by avian Influenza A (H5N1) - Chile. Apr 2023 [internet publication].全文
55. Castillo A, Fasce R, Parra B, et al. The first case of human infection with H5N1 avian Influenza A virus in Chile. J Travel Med. 2023 Sep 5;30(5):taad083.全文 摘要
56. Centers for Disease Control and Prevention. Human infection with highly pathogenic avian influenza A(H5N1) virus in Chile. Mar 2023 [internet publication].全文
57. World Health Organization. Disease outbreak news: avian influuenza A (H5N1) - Cambodia. Feb 2023 [internet publication].全文
58. World Health Organization. Disease outbreak news: human infection caused by avian influenza A(H5) - Ecuador. Jan 2023 [internet publication].全文
59. Bruno A, Alfaro-Núñez A, de Mora D, et al. First case of human infection with highly pathogenic H5 avian Influenza A virus in South America: A new zoonotic pandemic threat for 2023? J Travel Med. 2023 Sep 5;30(5):taad032.全文 摘要
60. World Health Organization. Update: WHO-confirmed human cases of avian influenza A (H5N1) infection, November 2003-May 2008. Wkly Epidemiol Rec. 2008 Nov 14;83(46):415-20. 摘要
61. Le MQ, Horby P, Fox A, et al. Subclinical avian influenza A(H5N1) virus infection in human, Vietnam. Emerg Infect Dis. 2013 Oct;19(10):1674-7.全文 摘要
62. Capelastegui F, Smith J, Kumbang J, et al. Pilot of asymptomatic swabbing of humans following exposures to confirmed avian influenza A(H5) in avian species in England, 2021/2022. Influenza Other Respir Viruses. 2023 Aug;17(8):e13187.全文 摘要
63. Aznar E, Casas I, González Praetorius A, et al. Influenza A(H5N1) detection in two asymptomatic poultry farm workers in Spain, September to October 2022: suspected environmental contamination. Euro Surveill. 2023 Feb;28(8):2300107.全文 摘要
64. Oliver I, Roberts J, Brown CS, et al. A case of avian influenza A(H5N1) in England, January 2022. Euro Surveill. 2022 Feb;27(5):2200061.全文 摘要
65. Qi Y, Ni HB, Chen X, et al. Seroprevalence of highly pathogenic avian influenza (H5N1) virus infection among humans in mainland China: a systematic review and meta-analysis. Transbound Emerg Dis. 2020 Sep;67(5):1861-71. 摘要
66. Gomaa MR, El Rifay AS, Abu Zeid D, et al. Incidence and seroprevalence of avian influenza in a cohort of backyard poultry growers, Egypt, Aug 2015-Mar 2019. Emerg Infect Dis. 2020 Sep;26(9):2129-36.全文 摘要
67. Tong S, Zhu X, Li Y, et al. New world bats harbor diverse influenza A viruses. PLoS Pathog. 2013;9(10):e1003657.全文 摘要
68. Centers for Disease Control and Prevention. Bird flu in animals and people: causes and how it spreads. May 2022 [internet publication].全文
69. Areechokchai D, Jiraphongsa C, Laosiritaworn Y, et al. Investigation of avian influenza (H5N1) outbreak in humans: Thailand, 2004. MMWR Morb Mortal Wkly Rep. 2006 Apr 28;55(1):3-6.全文 摘要
70. Dinh PN, Long HT, Tien NT, et al. Risk factors for human infection with avian influenza A H5N1, Vietnam, 2004. Emerg Infect Dis. 2006 Dec;12(12):1841-7.全文 摘要
71. World Health Organization. Update on human cases of highly pathogenic avian influenza A(H5N1) virus infection, 2011. Wkly Epidemiol Rec. 2012 Mar 30;87(13):117-23.全文 摘要
72. Mounts AW, Kwong H, Izurieta HS, et al. Case-control study of risk factors for avian influenza A (H5N1) disease, Hong Kong, 1997. J Infect Dis. 1999 Aug;180(2):505-8. 摘要
73. Zhou L, Liao Q, Dong L, et al. Risk factors for human illness with avian influenza A (H5N1) virus infection in China. J Infect Dis. 2009 Jun 15;199(12):1726-34.全文 摘要
74. Wan XF, Dong L, Lan Y, et al. Indications that live poultry markets are a major source of human H5N1 influenza virus infection in China. J Virol. 2011 Dec;85(24):13432-8.全文 摘要
75. Cavailler P, Chu S, Ly S, et al. Seroprevalence of anti-H5 antibody in rural Cambodia, 2007. J Clin Virol. J Clin Virol. 2010 Jun;48(2):123-6. 摘要
76. Kandun IN, Tresnaningsih E, Purba WH, et al. Factors associated with case fatality of human H5N1 virus infections in Indonesia: a case series. Lancet. 2008 Aug 30;372(9640):744-9. 摘要
77. Horby P, Sudoyo H, Viprakasit V, et al. What is the evidence of a role for host genetics in susceptibility to influenza A/H5N1? Epidemiol Infect. 2010 Nov;138(11):1550-8.全文 摘要
78. Human cases of avian influenza A (H5N1) in North-West Frontier Province, Pakistan, October-November 2007. Wkly Epidemiol Rec. 2008 Oct 3;83(40):359-64. 摘要
79. Aditama TY, Samaan G, Kusriastuti R, et al. Risk factors for cluster outbreaks of avian influenza A H5N1 infection, Indonesia. Clin Infect Dis. 2011 Dec;53(12):1237-44.全文 摘要
80. Aditama TY, Samaan G, Kusriastuti R, et al. Avian influenza H5N1 transmission in households, Indonesia. PLoS One. 2012;7(1):e29971.全文 摘要
81. Kandun IN, Wibisono H, Sedyaningsih ER, et al. Three Indonesian clusters of H5N1 virus infection in 2005. N Engl J Med. 2006 Nov 23;355(21):2186-94.全文 摘要
82. Beigel JH, Farrar J, Han AM, et al. Avian influenza A (H5N1) infection in humans. N Engl J Med. 2005 Sep 29;353(13):1374-85.全文 摘要
83. Imai M, Watanabe T, Hatta M, et al. Experimental adaptation of an influenza H5 HA confers respiratory droplet transmission to a reassortant H5 HA/H1N1 virus in ferrets. Nature. 2012 May 2;486(7403):420-8.全文 摘要
84. Centers for Disease Control and Prevention. Study shows ferrets became sick with A(H5N1) virus after eye exposure. Jun 2024 [internet publication].全文
85. Neumann G, Macken CA, Karasin AI, et al. Egyptian H5N1 influenza viruses-cause for concern? PLoS Pathog. 2012;8(11):e1002932.全文 摘要
86. Russell CA, Fonville JM, Brown AE, et al. The potential for respiratory droplet-transmissible A/H5N1 influenza virus to evolve in a mammalian host. Science. 2012 Jun 22;336(6088):1541-7.全文 摘要
87. Uyeki TM, Bresee JS. Detecting human-to-human transmission of avian influenza A (H5N1). Emerg Infect Dis. 2007 Dec;13(12):1969-71.全文 摘要
88. Refaey S, Azziz-Baumgartner E, Amin MM, et al. Increased number of human cases of influenza virus A(H5N1) infection, Egypt, 2014-15. Emerg Infect Dis. 2015 Dec;21(12):2171-3.全文 摘要
89. Garten RJ, Davis CT, Russell CA, et al. Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans. Science. 2009 Jul 10;325(5937):197-201.全文 摘要
90. Horimoto T, Kawaoka Y. Influenza: lessons from past pandemics, warnings from current incidents. Nat Rev Microbiol. 2005 Aug;3(8):591-600. 摘要
91. Yamada S, Suzuki Y, Suzuki T, et al. Haemagglutinin mutations responsible for the binding of H5N1 influenza A viruses to human-type receptors. Nature. 2006 Nov 16;444(7117):378-82. 摘要
92. van Riel D, Munster VJ, de Wit E, et al. H5N1 virus attachment to lower respiratory tract. Science. 2006 Apr 21;312(5772):399. 摘要
93. Shu Y, Li CK, Li Z, et al. Avian influenza A(H5N1) viruses can directly infect and replicate in human gut tissues. J Infect Dis. 2010;201:1173-1177. 摘要
94. Chandrasekaran A, Srinivasan A, Raman R, et al. Glycan topology determines human adaptation of avian H5N1 virus hemagglutinin. Nat Biotechnol. 2008 Jan;26(1):107-13. 摘要
95. Auewarakul P, Suptawiwat O, Kongchanagul A, et al. An avian influenza H5N1 virus that binds to a human-type receptor. J Virol. 2007 Sep;81(18):9950-5.全文 摘要
96. Chan MC, Cheung CY, Chui WH, et al. Proinflammatory cytokine responses induced by influenza A (H5N1) viruses in primary human alveolar and bronchial epithelial cells. Respir Res. 2005 Nov 11;6(1):135.全文 摘要
97. de Jong MD, Simmons CP, Thanh TT, et al. Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia. Nat Med. 2006 Oct;12(10):1203-7.全文 摘要
98. Gu J, Xie Z, Gao Z, et al. H5N1 infection of the respiratory tract and beyond: a molecular pathology study. Lancet. 2007 Sep 29;370(9593):1137-45. 摘要
99. Apisarnthanarak A, Erb S, Stephenson I, et al. Seroprevalence of anti-H5 antibody among Thai health care workers after exposure to avian influenza (H5N1) in a tertiary care center. Clin Infect Dis. 2005 Jan 15;40(2):e16-8. 摘要
100. Liem NT, Lim W. Lack of H5N1 avian influenza transmission to hospital employees, Hanoi, 2004. Emerg Infect Dis. 2005 Feb;11(2):210-5.全文 摘要
101. Schultsz C, Dong VC, Chau NV, et al. Avian influenza H5N1 and healthcare workers. Emerg Infect Dis. 2005 Jul;11(7):1158-9.全文 摘要
102. Ortiz JR, Katz MA, Mahmoud MN, et al. Lack of evidence of avian-to-human transmission of avian influenza A (H5N1) virus among poultry workers, Kano, Nigeria, 2006. J Infect Dis. 2007 Dec 1;196(11):1685-91.全文 摘要
103. World Health Organization. Practical interim guidance to reduce the risk of infection in people exposed to avian influenza viruses. Aug 2024 [internet publication].全文
104. UK Health Security Agency. Management of contacts of highly pathogenic avian influenza H5N1 during the 2023 to 2024 avian influenza season. Feb 2024 [internet publication].全文
105. Prieto-Lara E, Llanos-Mendez A. Safety and immunogenicity of prepandemic H5N1 influenza vaccines: a systematic review of the literature. Vaccine. 2010 Jun 11;28(26):4328-34. 摘要
106. Vesikari T, Forstén A, Herbinger KH, et al. Safety and immunogenicity of an MF59(®)-adjuvanted A/H5N1 pre-pandemic influenza vaccine in adults and the elderly. Vaccine. 2012 Feb 8;30(7):1388-96. 摘要
107. Langley JM, Risi G, Caldwell M, et al. Dose-sparing H5N1 A/Indonesia/05/2005 pre-pandemic influenza vaccine in adults and elderly adults: a phase III, placebo-controlled, randomized study. J Infect Dis. 2011 Jun 15;203(12):1729-38.全文 摘要
108. US Food and Drug Administration. Influenza virus vaccine, H5N1 (for national stockpile). Feb 2018 [internet publication].全文
109. Qualls N, Levitt A, Kanade N, et al; CDC Community Mitigation Guidelines Work Group. Community mitigation guidelines to prevent pandemic influenza - United States, 2017. MMWR Recomm Rep. 2017 Apr 21;66(1):1-34.全文 摘要
110. Centers for Disease Control and Prevention. Case definitions for investigations of human infection with avian influenza A viruses in the United States. May 2024 [internet publication].全文
111. World Health Organization. Interim guidelines for avian influenza case management. Sep 2007 [internet publication].全文
112. Centers for Disease Control and Prevention. Interim guidance on specimen collection and testing for patients with suspected infection with novel influenza A viruses associated with severe disease or with the potential to cause severe disease in humans. Sep 2024 [internet publication].全文
113. World Health Organization. Clinical practice guidelines for influenza. Sep 2024 [internet publication].全文
114. European Centre for Disease Prevention and Control. Enhanced surveillance of severe avian influenza virus infections in hospital settings in the EU/EEA. Jun 2023 [internet publication].全文
115. Centers for Disease Control and Prevention. Interim guidance for infection control within healthcare settings when caring for confirmed cases, probable cases, and cases under investigation for infection with novel influenza A viruses associated with severe disease. Mar 2022 [internet publication].全文
116. World Health Organization. Collecting, preserving and shipping specimens for the diagnosis of avian influenza A(H5N1) virus infection. Oct 2006 [internet publication].全文
117. UK Health Security Agency. Laboratory investigations for suspected avian influenza A(H7) and A(H5) human infections in England. 2022 [internet publication].全文
118. UK Health Security Agency. Avian influenza: guidance for managing human cases. Feb 2024 [internet publication].全文
119. Centers for Disease Control and Prevention. Symptom monitoring among persons exposed to HPAI. Jun 2024 [internet publication].全文
120. Centers for Disease Control and Prevention. Interim guidance for follow-up of close contacts of persons infected with novel influenza A viruses associated with severe human disease or with potential to cause severe human disease, and use of antiviral medications for post-exposure prophylaxis. Aug 2024 [internet publication].全文
121. Patel RB, Mathur MB, Gould M, et al. Demographic and clinical predictors of mortality from highly pathogenic avian influenza A (H5N1) virus infection: CART analysis of international cases. PLoS One. 2014 Mar 25;9(3):e91630.全文 摘要
122. Centers for Disease Control and Prevention. Influenza antiviral medications: summary for clinicians. Dec 2023 [internet publication].全文
123. Adisasmito W, Chan PK, Lee N, et al. Effectiveness of antiviral treatment in human influenza A (H5N1) infections: analysis of a Global Patient Registry. J Infect Dis. 2010 Oct 15;202(8):1154-60.全文 摘要
124. Chan PK, Lee N, Zaman M, et al. Determinants of antiviral effectiveness in influenza virus A subtype H5N1. J Infect Dis. 2012 Nov;206(9):1359-66. 摘要
125. Duval X, van der Werf S, Blanchon T, et al. Efficacy of oseltamivir-zanamivir combination compared to each monotherapy for seasonal influenza: a randomized placebo-controlled trial. PLoS Med. 2010 Nov 2;7(11):e1000362.全文 摘要
126. Kayali G, Webby RJ, Ducatez MF, et al. The epidemiological and molecular aspects of influenza H5N1 viruses at the human-animal interface in Egypt. PLoS One. 2011 Mar 21;6(3):e17730.全文 摘要
127. Fiebig L, Soyka J, Buda S, et al. Avian influenza A(H5N1) in humans: new insights from a line list of World Health Organization confirmed cases, September 2006 to August 2010. Euro Surveill. 2011 Aug 11;16(32):19941.全文 摘要
128. Arabi Y, Gomersall CD, Ahmed QA, et al. The critically ill avian influenza A (H5N1) patient. Crit Care Med. 2007 May;35(5):1397-403. 摘要
129. de Jong MD, Tran TT, Truong HK, et al. Oseltamivir resistance during treatment of influenza A (H5N1) infection. N Engl J Med. 2005;353:2667-2672.全文 摘要
130. Le QM, Kiso M, Someya K, et al. Avian flu: isolation of drug-resistant H5N1 virus. Nature. 2005 Oct 20;437(7062):1108. 摘要
131. Le MT, Wertheim HF, Nguyen HD, et al. Influenza A H5N1 clade 2.3.4 virus with a different antiviral susceptibility profile replaced clade 1 virus in humans in northern Vietnam. PLoS One. 2008 Oct 6;3(10):e3339.全文 摘要
132. Centers for Disease Control and Prevention. Interim guidance on influenza antiviral post-exposure prophylaxis of persons exposed to birds or other animals with novel influenza A viruses associated with severe human disease or with the potential to cause severe human disease. Sep 2024 [internet publication].全文
133. Taylor WR, Thinh BN, Anh GT, et al. Oseltamivir is adequately absorbed following nasogastric administration to adult patients with severe H5N1 influenza. PLoS One. 2008;3(10):e3410.全文 摘要
134. Zhou B, Zhong N, Guan Y. Treatment with convalescent plasma for influenza A (H5N1) infection. N Engl J Med. 2007 Oct 4;357(14):1450-1.全文 摘要
135. Yu H, Gao Z, Feng Z, et al. Clinical characteristics of 26 human cases of highly pathogenic avian influenza A (H5N1) virus infection in China. PLoS One. 2008 Aug 21;3(8):e2985.全文 摘要
136. Lee CM, Hudson LD. Long-term outcomes after ARDS. Semin Respir Crit Care Med. 2001 Jun;22(3):327-36. 摘要
内容使用需遵循免责声明